| Patent | Date |
|---|
Protein Tyrosine Phosphatase Inhibitors
App 20220251083 - BLAKE; James Francis ; et al. | 2022-08-11 |
Bicyclic fused pyridine compounds as inhibitors of TAM kinases
Grant 11,247,990 - Allen , et al. February 15, 2 | 2022-02-15 |
Protein Tyrosine Phosphatase Inhibitors
App 20210380582 - BLAKE; James Francis ; et al. | 2021-12-09 |
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
Grant 11,028,093 - Allen , et al. June 8, 2 | 2021-06-08 |
Protein Tyrosine Phosphatase Inhibitors
App 20200317665 - BLAKE; James F. ; et al. | 2020-10-08 |
4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS
App 20200291039 - Allen; Shelley ; et al. | 2020-09-17 |
4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors
Grant 10,730,880 - Allen , et al. | 2020-08-04 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
Grant 10,669,269 - Boys , et al. | 2020-06-02 |
4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS
App 20190177328 - Allen; Shelley ; et al. | 2019-06-13 |
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
Grant 10,189,845 - Allen , et al. Ja | 2019-01-29 |
SUBSTITUTED N-(lH-INDAZOL-4-YL)IMIDAZO[l,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS
App 20180086758 - Boys; Mark Laurence ; et al. | 2018-03-29 |
4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS
App 20170362240 - Allen; Shelley ; et al. | 2017-12-21 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
Grant 9,809,590 - Boys , et al. November 7, 2 | 2017-11-07 |
SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS
App 20160002232 - Boys; Mark Laurence ; et al. | 2016-01-07 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
Grant 9,174,981 - Boys , et al. November 3, 2 | 2015-11-03 |
5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases
Grant 8,962,596 - Burgess , et al. February 24, 2 | 2015-02-24 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors
Grant 8,841,455 - Boys , et al. September 23, 2 | 2014-09-23 |
5,7-substituted-imidazo[1,2-c]pyrimidines
App 20140228349 - Boys; Mark Laurence ; et al. | 2014-08-14 |
Substituted N-(1h-indazol-4-yl)imidazo[1,2-]pyridine-3-carboxamide Compounds As Type Iii Receptor Tyrosine Kinase Inhibitors
App 20130274244 - Boys; Mark Laurence ; et al. | 2013-10-17 |
5,7-substituted-imidazo[1,2-c]pyrimidines As Inhibitors Of Jak Kinases
App 20130131039 - Burgess; Laurence E. ; et al. | 2013-05-23 |
Substituted N-(1H-Indazol-4-yl)Imidazo[1,2-a]Pyridine-3-Carboxamide Compounds as cFMS Inhibitors
App 20120258952 - Boys; Mark Laurence ; et al. | 2012-10-11 |
Androgen Modulators
App 20090170886 - Boys; Mark Laurence ; et al. | 2009-07-02 |
Heteroarylalkanoic acids as integrin receptor antagonists
Grant 6,933,304 - Nagarajan , et al. August 23, 2 | 2005-08-23 |
Heteroarylalkanoic acids as integrin receptor antagonists
App 20020133023 - Nagarajan, Srinivasan Raj ; et al. | 2002-09-19 |
Asymmetric synthesis of chiral beta-amiNo acids
Grant 5,840,961 - Behling , et al. November 24, 1 | 1998-11-24 |
| 